Persistent infection with high-risk human papillomavirus (hrHPV) is a key step in the development of cervical cancer. However, making clinical decisions about how to deal with these cases has become a challenge for obstetrics and gynecology (Ob/Gyn) practitioners. Here, we review the latest research findings and propose possible solutions for the management of persistent hrHPV infections.
基金：
National Natural Science Foundation of China [81372806, 81230038, 81472783, 81630060]; National Key Research & Development Program of China [2016YFC1302900, 2016YFC0902900, 2015CB553903]
第一作者单位：[1]Huazhong Univ Sci & Technol, Key Lab Canc Invas & Metastasis, Minist Educ, Tongji Hosp,Tongji Med Coll, Wuhan 430030, Hubei, Peoples R China
通讯作者：
推荐引用方式(GB/T 7714)：
Meng Yifan,Ma Ding,Wu Peng.A Common Clinical Dilemma: Management of Persistent hrHPV Infection[J].TRENDS IN CANCER.2017,3(5):315-318.doi:10.1016/j.trecan.2017.03.010.
APA：
Meng, Yifan,Ma, Ding&Wu, Peng.(2017).A Common Clinical Dilemma: Management of Persistent hrHPV Infection.TRENDS IN CANCER,3,(5)
MLA：
Meng, Yifan,et al."A Common Clinical Dilemma: Management of Persistent hrHPV Infection".TRENDS IN CANCER 3..5(2017):315-318
：
医学